← The Wire
BLTENasdaq
BELITE BIO, INC
Pharmaceutical Preparations · E9 · CIK 1889109
BELITE BIO, INC develops and commercializes novel therapeutics for rare genetic diseases
$5.54B
Market cap
$154.65
Last close
+4.0%
1D
+5.2%
5D
195K
Volume
Price · last 39 sessions+0.1%
May 4L $134.93 · H $156.21Jun 29
69
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
6-KFORM 6-KJun 15, 20266-KFORM 6-KMay 20, 20266-K6-KApr 21, 20266-KFORM 6-KMar 31, 202620-F20-FMar 31, 20266-KFORM 6-KMar 2, 20266-KFORM 6-KJan 27, 2026424B5424B5Dec 2, 20256-KFORM 6-KDec 2, 2025424B5424B5Dec 1, 20256-KFORM 6-KDec 1, 20256-KFORM 6-KDec 1, 20256-KFORM 6-KDec 1, 20256-KFORM 6-KNov 10, 20256-KFORM 6-KSep 8, 20256-KFORM 6-KAug 11, 2025424B5424B5Aug 8, 20256-KFORM 6-KAug 7, 20256-KFORM 6-KJul 2, 20256-KFORM 6-KMay 21, 20256-KFORM 6-KMay 14, 20256-KFORM 6-KApr 15, 20256-KFORM 6-KMar 28, 20256-KFORM 6-KMar 18, 20256-KFORM 6-KMar 17, 20256-KFORM 6-KMar 17, 202520-F20-FMar 17, 20256-KFORM 6-KFeb 27, 2025424B5424B5Feb 7, 20256-KFORM 6-KFeb 6, 20256-KFORM 6-KNov 12, 20246-KFORM 6-KNov 4, 20246-KFORM 6-KSep 3, 20246-KFORM 6-KAug 9, 20246-KFORM 6-KMay 14, 2024424B5424B5Apr 29, 20246-KFORM 6-KApr 26, 20246-KFORM 6-KMar 22, 20246-KFORM 6-KMar 12, 202420-FFORM 20-FMar 12, 20246-KFORM 6-KMar 12, 2024SC 13GSC 13GFeb 12, 2024SC 13GSC 13GFeb 12, 20246-KFORM 6-KNov 14, 20236-KFORM 6-KNov 6, 20236-KFORM 6-KAug 9, 20236-KFORM 6-KJul 24, 20236-KFORM 6-KJun 16, 2023424B5424B5Jun 16, 2023424B5424B5Jun 1, 20236-KFORM 6-KMay 31, 20236-KFORM 6-KMay 30, 2023424B5424B5May 30, 20236-KFORM 6-KMay 11, 20236-KFORM 6-KApr 25, 20236-KFORM 6-KApr 3, 202320-FFORM 20-FMar 31, 2023SC 13GSC 13GFeb 15, 2023SC 13GSC 13GFeb 14, 20236-KFORM 6-KDec 13, 20226-KFORM 6-KNov 18, 20226-KFORM 6-KOct 3, 20226-KFORM 6-KSep 16, 20226-KFORM 6-KAug 22, 20226-KFORM 6-KAug 11, 20226-KFORM 6-KJul 19, 20226-KFORM 6-KMay 12, 20226-KFORM 6-KMay 3, 2022424B4424B4Apr 29, 2022
Similar companies
Comparable business profile · signals at a glance